{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:23:48Z","timestamp":1785414228951,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Poor ovarian response (POR) is among the common findings in infertile women with no significant underlying condition. The aim of this study was to investigate the intra-ovarian potential of platelet-rich plasma (PRP) administration on oocytes-dependent variables in the POR women grouped according to the POSEIDON criteria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study was performed on POR women with no underlying condition who have undergone intra-ovarian PRP injection. As well as patients\u2019 age, the number of total and MI, MII, and GV oocytes were extracted from the files. The laboratory variables including anti-mullerian hormone (AMH), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol were also gathered. In order to reduce any bias due to the possible differences in kits or devices, a single laboratory with the highest number of cases was selected and others were excluded from the study. Then, the included cases were grouped into four according to the POSEIDON criteria and analyzed for the mentioned variables by SPSS, version 25. The statistical significance level was set as <jats:italic>P<\/jats:italic>-value\u2009&lt;\u20090.05.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From 383 cases, a total number of 96 women were enrolled in this study. According to the POSEIDON criteria, group 4 (Age\u2009\u2265\u200935\u00a0years, AMH\u2009&lt;\u20091.2\u00a0ng\/mL) with the ratio of 56\/96 (58.3%) had the highest prevalence among others. As the analyses showed, changes in the laboratory variables (LH, FSH, AMH, and estradiol) were not significant in almost all the groups following the intervention. Regarding the total oocytes number, PRP administration caused a significant increase in the total number in all the groups (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Also, the number of MII oocytes was significantly increased following the treatment in all groups except for group 2 (Age\u2009\u2265\u200935\u00a0years, AMH\u2009\u2265\u20091.2\u00a0ng\/mL; all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Of 96 cases, 14 (14.6%) got clinically pregnant following assisted reproductive techniques which this number were significantly differed among the groups (<jats:italic>P<\/jats:italic>\u2009=\u20090.002).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study showed that PRP treatment was effective on total and MII oocyte numbers in the patients with POR, however, further studies are required.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-021-00826-w","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T08:03:03Z","timestamp":1631088183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria"],"prefix":"10.1186","volume":"19","author":[{"given":"Marzieh","family":"Farimani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrzad","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghayeh","family":"Anvari Aliabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"826_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1196\/annals.1434.011","volume":"1127","author":"ME Coccia","year":"2008","unstructured":"Coccia ME, Rizzello F. Ovarian reserve. Ann N Y Acad Sci. 2008;1127:27\u201330. https:\/\/doi.org\/10.1196\/annals.1434.011.","journal-title":"Ann N Y Acad Sci"},{"key":"826_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/s0015-0282(99)00630-5","volume":"73","author":"ES Surrey","year":"2000","unstructured":"Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000;73:667\u201376. https:\/\/doi.org\/10.1016\/s0015-0282(99)00630-5.","journal-title":"Fertil Steril"},{"key":"826_CR3","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"C Alviggi","year":"2016","unstructured":"Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, et al. A new more detailed stratification of low responders to ovarian stimulation: From a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105:1452\u20133. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.02.005.","journal-title":"Fertil Steril"},{"key":"826_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fendo.2019.00281","volume":"10","author":"V Grisendi","year":"2019","unstructured":"Grisendi V, Mastellari E, La Marca A. Ovarian reserve markers to identify poor responders in the context of Poseidon classification. Front Endocrinol. 2019;10:281. https:\/\/doi.org\/10.3389\/fendo.2019.00281.","journal-title":"Front Endocrinol"},{"key":"826_CR5","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616\u201324. https:\/\/doi.org\/10.1093\/humrep\/der092.","journal-title":"Hum Reprod"},{"key":"826_CR6","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3389\/fendo.2019.00814","volume":"10","author":"SC Esteves","year":"2019","unstructured":"Esteves SC, Alviggi C, Humaidan P, Fischer R, Andersen CY, Conforti A, et al. The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists. Front Endocrinol. 2019;10:814. https:\/\/doi.org\/10.3389\/fendo.2019.00814.","journal-title":"Front Endocrinol"},{"key":"826_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.transci.2016.12.032","volume":"56","author":"S Mohammadi","year":"2017","unstructured":"Mohammadi S, Nasiri S, Mohammadi MH, Malek Mohammadi A, Nikbakht M, Zahed Panah M, et al. Evaluation of platelet-rich plasma gel potential in acceleration of wound healing duration in patients underwent pilonidal sinus surgery: A randomized controlled parallel clinical trial. Transfus Apher Sci. 2017;56:226\u201332. https:\/\/doi.org\/10.1016\/j.transci.2016.12.032.","journal-title":"Transfus Apher Sci"},{"key":"826_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.transci.2016.10.020","volume":"56","author":"MH Mohammadi","year":"2017","unstructured":"Mohammadi MH, Molavi B, Mohammadi S, Nikbakht M, Mohammadi AM, Mostafaei S, et al. Evaluation of wound healing in diabetic foot ulcer using platelet-rich plasma gel: A single-arm clinical trial. Transfus Apher Sci. 2017;56:160\u20134. https:\/\/doi.org\/10.1016\/j.transci.2016.10.020.","journal-title":"Transfus Apher Sci"},{"key":"826_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00266-014-0374-7","volume":"38","author":"JM Serra-Mestre","year":"2014","unstructured":"Serra-Mestre JM, Serra-Renom JM, Martinez L, Almadori A, D\u2019Andrea F. Platelet-rich plasma mixed-fat grafting: A reasonable prosurvival strategy for fat grafts? Aesthetic Plast Surg. 2014;38:1041\u20139. https:\/\/doi.org\/10.1007\/s00266-014-0374-7.","journal-title":"Aesthetic Plast Surg"},{"key":"826_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jama.2009.1986","volume":"303","author":"RJ de Vos","year":"2010","unstructured":"de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA. 2010;303:144\u20139. https:\/\/doi.org\/10.1001\/jama.2009.1986.","journal-title":"JAMA"},{"key":"826_CR11","first-page":"172","volume":"16","author":"M Farimani","year":"2016","unstructured":"Farimani M, Bahmanzadeh M, Poorolajal J. A new approach using autologous platelet-rich plasma (PRP) to treat infertility and to improve population replacement rate. J RE Health Sci. 2016;16:172\u20133.","journal-title":"J RE Health Sci"},{"key":"826_CR12","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s11033-019-04609-w","volume":"46","author":"M Farimani","year":"2019","unstructured":"Farimani M, Heshmati S, Poorolajal J, Bahmanzadeh M. A report on three live births in women with poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP). Mol Biol Rep. 2019;46:1611\u20136. https:\/\/doi.org\/10.1007\/s11033-019-04609-w.","journal-title":"Mol Biol Rep"},{"key":"826_CR13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10815-018-1159-8","volume":"35","author":"A Bos-Mikich","year":"2018","unstructured":"Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet. 2018;35:753\u20136. https:\/\/doi.org\/10.1007\/s10815-018-1159-8.","journal-title":"J Assist Reprod Genet"},{"key":"826_CR14","doi-asserted-by":"publisher","first-page":"10211","DOI":"10.18632\/aging.103403","volume":"12","author":"Y Cakiroglu","year":"2020","unstructured":"Cakiroglu Y, Saltik A, Yuceturk A, Karaosmanoglu O, Kopuk SY, Scott RT, et al. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging. 2020;12:10211\u201322. https:\/\/doi.org\/10.18632\/aging.103403.","journal-title":"Aging"},{"key":"826_CR15","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1007\/s43032-021-00483-9","volume":"28","author":"A Aflatoonian","year":"2021","unstructured":"Aflatoonian A, Lotfi M, Saeed L, Tabibnejad N. Effects of intraovarian injection of autologous platelet-rich plasma on ovarian rejuvenation in poor responders and women with primary ovarian insufficiency. Reprod Sci. 2021;28:2050\u20139. https:\/\/doi.org\/10.1007\/s43032-021-00483-9.","journal-title":"Reprod Sci"},{"key":"826_CR16","first-page":"803","volume":"15","author":"M Farimani","year":"2017","unstructured":"Farimani M, Poorolajal J, Rabiee S, Bahmanzadeh M. Successful pregnancy and live birth after intrauterine administration of autologous platelet-rich plasma in a woman with recurrent implantation failure: A case report. Int J Reproduct Biomed. 2017;15:803\u20136.","journal-title":"Int J Reproduct Biomed"},{"key":"826_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13048-015-0204-9","volume":"8","author":"JS Younis","year":"2015","unstructured":"Younis JS, Ben-Ami M, Ben-Shlomo I. The Bologna criteria for poor ovarian response: A contemporary critical appraisal. Journal of ovarian research. 2015;8:76. https:\/\/doi.org\/10.1186\/s13048-015-0204-9.","journal-title":"Journal of ovarian research"},{"key":"826_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bj.2019.05.002","volume":"42","author":"S Mohamadi","year":"2019","unstructured":"Mohamadi S, Norooznezhad AH, Mostafaei S, Nikbakht M, Nassiri S, Safar H, et al. A randomized controlled trial of effectiveness of platelet-rich plasma gel and regular dressing on wound healing time in pilonidal sinus surgery: Role of different affecting factors. Biomed J. 2019;42:403\u201310. https:\/\/doi.org\/10.1016\/j.bj.2019.05.002.","journal-title":"Biomed J"},{"key":"826_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","volume":"29","author":"Y Kuang","year":"2014","unstructured":"Kuang Y, Chen Q, Hong Q, Lyu Q, Ai A, Fu Y, et al. Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol). Reprod Biomed Online. 2014;29:684\u201391. https:\/\/doi.org\/10.1016\/j.rbmo.2014.08.009.","journal-title":"Reprod Biomed Online"},{"key":"826_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19396368.2020.1862357","volume":"67","author":"H Hajipour","year":"2021","unstructured":"Hajipour H, Farzadi L, Latifi Z, Keyhanvar N, Navali N, Fattahi A, et al. An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: clinical and molecular aspects. Syst Biol Reprod Med. 2021;67:1\u201312. https:\/\/doi.org\/10.1080\/19396368.2020.1862357.","journal-title":"Syst Biol Reprod Med."},{"key":"826_CR21","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/wrr.12597","volume":"25","author":"S Mostafaei","year":"2017","unstructured":"Mostafaei S, Norooznezhad F, Mohammadi S, Norooznezhad AH. Effectiveness of platelet-rich plasma therapy in wound healing of pilonidal sinus surgery: A comprehensive systematic review and meta-analysis. Wound Repair Regen. 2017;25:1002\u20137. https:\/\/doi.org\/10.1111\/wrr.12597.","journal-title":"Wound Repair Regen"},{"key":"826_CR22","first-page":"1","volume":"83","author":"KM Lacci","year":"2010","unstructured":"Lacci KM, Dardik A. Platelet-rich plasma: Support for its use in wound healing. Yale J Biol Med. 2010;83:1\u20139.","journal-title":"Yale J Biol Med"},{"key":"826_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3389\/fendo.2019.00775","volume":"10","author":"MH Cai","year":"2019","unstructured":"Cai MH, Gao LZ, Liang XY, Fang C, Wu YQ, Yang X. The effect of growth hormone on the clinical outcomes of poor ovarian reserve patients undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment: A retrospective study based on POSEIDON criteria. Front Endocrinol (Lausanne). 2019;10:775. https:\/\/doi.org\/10.3389\/fendo.2019.00775.","journal-title":"Front Endocrinol (Lausanne)"}],"updated-by":[{"DOI":"10.1186\/s12958-021-00849-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000}}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-021-00826-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-021-00826-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-021-00826-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T03:04:02Z","timestamp":1637204642000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-021-00826-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1186\/s12958-021-00826-w","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"16 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12958-021-00849-3","URL":"https:\/\/doi.org\/10.1186\/s12958-021-00849-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was approved by the Medical Ethics Committee of Hamedan University of Medical Sciences (Hamedan, Iran) with the IRB number of IR.UMSHA.REC.1399.725. The authors declare their adhered to the 1975 declaration of Helsinki and its next revisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients kindly signed a written consent form freely for publishing\/using of their medical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no actual or potential conflict of interests related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}